These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6990144)

  • 1. [Renal dysfunction in liver cirrhosis. Clinical and physiopathological aspects].
    Dequiedt P; Tacquet A
    Lille Med; 1980 Mar; 25(3):68-73. PubMed ID: 6990144
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatorenal syndrome. Clinical and pathogenetic aspects and therapeutic approach].
    Marmo R; Persico M; Costume A; Bronzino P; Del Vecchio E; Gentile S; Porcellini M
    Clin Ter; 1984 Dec; 111(5):443-9. PubMed ID: 6151436
    [No Abstract]   [Full Text] [Related]  

  • 3. [Renal changes in cirrhosis].
    Hanson B; Vandermeeren A
    Rev Med Brux; 1988 May; 9(4):223-6. PubMed ID: 3406612
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and functional aspects of the kidney in relation to renal and intrarenal hemodynamic changes during hepatic cirrhosis].
    Gatta A; Merkel C; Milani L; Caregaro L; Grassetto M; Lauro S; Zuin R
    Minerva Nefrol; 1979; 26(1):37-40. PubMed ID: 381990
    [No Abstract]   [Full Text] [Related]  

  • 5. Deranged renal function in liver disease.
    Epstien M
    Contrib Nephrol; 1977; 7():250-71. PubMed ID: 330107
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy of lisinopril and nebivolol therapy of portal hypertension and kidney dysfunction in patients with liver cirrhosis].
    Fedulenkova LV; Drozdov VN; Mikheeva OM; Petrakov AV
    Eksp Klin Gastroenterol; 2008; (5):37-41. PubMed ID: 19145915
    [No Abstract]   [Full Text] [Related]  

  • 7. [Renal dysfunction in liver diseases].
    Rychalska-Glanc B
    Przegl Epidemiol; 1975; 29(2):229-33. PubMed ID: 1096246
    [No Abstract]   [Full Text] [Related]  

  • 8. Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites.
    Angeli P; Sanyal A; Moller S; Alessandria C; Gadano A; Kim R; Sarin SK; Bernardi M;
    Liver Int; 2013 Jan; 33(1):16-23. PubMed ID: 22507181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kidney lesion in liver diseases].
    Tareeva IE; Nikolaev AIu
    Klin Med (Mosk); 1980 May; 58(5):6-13. PubMed ID: 6991807
    [No Abstract]   [Full Text] [Related]  

  • 10. [Water-electrolyte metabolism in liver cirrhosis. Physiopathological and therapeutic aspects of reinfusion of concentrated ascitic fluid].
    Borghetti A; Fiaccadori F; Bruschi G; Coruzzi P; Guariglia A; Ghinelli F; Mutti A; Pasetti GC; Perinotto P; Novarini A
    Minerva Med; 1978 Jan; 69(1):53-66. PubMed ID: 628514
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal function and structure in subacute hepatic failure.
    Bal C; Longkumer T; Patel C; Gupta SD; Acharya SK
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1318-24. PubMed ID: 11129228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal concentrating ability in cirrhosis. I. Changes associated with the clinical status and course of the disease.
    Vaamonde CA; Vaamonde LS; Morosi HJ; Klingler EL; Papper S
    J Lab Clin Med; 1967 Aug; 70(2):179-94. PubMed ID: 6029052
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatorenal syndrome (a review of the literature)].
    Makovetskaia GA; Munina LN; Soshnikova MA; Kryshkovets DV
    Vopr Okhr Materin Det; 1978 Mar; 23(3):46-9. PubMed ID: 347708
    [No Abstract]   [Full Text] [Related]  

  • 14. Intrarenal resistance index for the assessment of early renal function impairment in patients with liver cirrhosis.
    Götzberger M; Kaiser C; Landauer N; Dieterle C; Heldwein W; Schiemann U
    Eur J Med Res; 2008 Aug; 13(8):383-7. PubMed ID: 18952521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal blood flow in hepatic cirrhosis determined by the Xe 133 washout method].
    Zuin R; Gatta A; Prandoni P; Finocchio GF; Merkel C; Ruol A
    Minerva Nefrol; 1976; 23(2):109-15. PubMed ID: 794762
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics and Tolerability of Intravenous Sildenafil in Two Subjects with Child-Turcotte-Pugh Class C Cirrhosis and Renal Dysfunction.
    Mindikoglu AL; Dowling TC; Schaub DJ; Hutson WR; Potosky DR; Christenson RH; Barth RN; LaMattina JC; Hanish SI; Weir MR; Raufman JP
    Dig Dis Sci; 2015 Nov; 60(11):3491-4. PubMed ID: 26143343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal function impairment in patients with cirrhosis having pulmonary hypertension.
    Kalambokis GN; Fotopoulos A; Pappas K; Tsianos EV
    Angiology; 2011 Oct; 62(7):585-7. PubMed ID: 21422055
    [No Abstract]   [Full Text] [Related]  

  • 18. Nitric oxide and renal functions in liver cirrhosis.
    Türkay C; Yönem O; Arikan O; Baskin E
    Turk J Gastroenterol; 2004 Jun; 15(2):73-6. PubMed ID: 15334313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical spectrum of renal disorders in patients with cirrhosis of liver.
    Prakash J; Mahapatra AK; Ghosh B; Arora P; Jain AK
    Ren Fail; 2011; 33(1):40-6. PubMed ID: 21219204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic renal insufficiency in the course of hepatic cirrhosis].
    Bercovici S; Cherciu S; Pambuccian G; Radian I; Palade C
    Med Interna (Bucur); 1965 Nov; 17(11):1293-301. PubMed ID: 5864341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.